Equity Overview
Price & Market Data
Price: $0.0027
Daily Change: -$0.00215 / 79.63%
Range: $0.0027 - $0.0027
Market Cap: $458,816
Volume: 536
Performance Metrics
1 Week: 63.70%
1 Month: -49.77%
3 Months: 22.78%
6 Months: 57.86%
1 Year: -60.18%
YTD: 26.29%
Details
Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005. The company also develops MYCO-006 and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.